New methods have been developed to study aspects of human development without crossing ethical boundaries determined by our societal values. Culturing embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) has allowed us to investigate some of the early steps in embryogenesis and to study certain processes that control human cellular differentiation in vitro. Single-cell transcriptomics now provides access to the genetic identity card of each individual cell type at a given moment, enabling its lineage to be traced over time in vivo. Finally, new three-dimensional imaging methods make it possible to map cells within developing tissues and organs.
HuDeCA’s main research objective is to establish the distinguishing molecular characteristics of single cells within specific embryonic and fetal organs at chosen stages, in order to define and map cell types. In order to meet that goal and to structure human embryology research in France, the consortium has established a dedicated, scalable human embryonic/fetal biobank to track and distribute samples among researchers within the consortium and, ultimately, to other research teams. These samples can be used for different types of analyses, such as genomic and transcriptomics studies or studies based on bioimaging methods.
Over the long term, results from this program will serve as a basis for understanding the origins of congenital diseases and mal-formations, which affect over 28,000 children and fetuses per year in France, i.e. 3% of births, and which also cause many chronic or late-onset diseases in adults.